Confluence Wealth Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Confluence Wealth Services's EW Position: Q2 2026 in Review
Confluence Wealth Services sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 3,484 shares — an estimated $279K sold.
Confluence Wealth Services first reported a position in EW in Q4 2021 and held it in 18 quarters. The position peaked at $529K in Q2 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Confluence Wealth Services reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Confluence Wealth Services sold 3,484 Edwards Lifesciences shares in Q2 2026, an estimated $279K.
- Confluence Wealth Services first reported a position in Edwards Lifesciences in Q4 2021 and held it in 18 quarters.
- Confluence Wealth Services's Edwards Lifesciences position peaked at $529K in Q2 2024.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.